Tumor safety of biologic agents and targeted therapies in immune-mediated inflammatory arthritides

Immune-mediated inflammatory arthritides (IMIA), including rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis, and juvenile idiopathic arthritis, are chronic immune-driven disorders in which long-term malignancy safety has become a key determinant of therapeutic decision-making. Pati...

Description complète

Détails bibliographiques

Auteurs principaux:	Sheng-Guang Li, Yadan Zou, Ji Li, Lina Zhang, Jing Zhang, Ting Long, Ruohan Yu, Yanfeng Zhang
Format:	Artigo
Langue:	Inglês
Publié:	Frontiers Media S.A. 2026-06-01
Collection:	Frontiers in Immunology
Sujets:	axial spondyloarthritis biologic DMARDs cancer risk immune-mediated inflammatory arthritides JAK inhibitors malignancy
Accès en ligne:	https://www.frontiersin.org/articles/10.3389/fimmu.2026.1827981/full
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!